SIRION Biotech, Denali Therapeutics to Develop New AAV Vectors to Help Treat ALS - ALS News Today

SIRION Biotech, Denali Therapeutics to Develop New AAV Vectors to Help Treat ALS  ALS News Today

SIRION Biotech and Denali Therapeutics have signed a new licensing agreement to develop a new generation of adeno-associated virus (AAV) vectors, ...